Product Images Lacosamide
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Lacosamide NDC 0904-7247 by Major Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a description of a medication called Lacosamide. The medication comes in tablet form and each tablet contains 200 mg of Lacosamide. The usual dosage for this medication is listed on the product insert, which contains dosage information, precautions, and warnings. This medication should be stored at room temperature and kept out of reach of children or anyone who should not have access to it. Pharmacist dispensing is required, and the tablets come in packages of 60.*
This is a description of a medication called Lacosamide. It comes in tablet form and is available in a package of 60 tablets, with each tablet containing 150mg of Lacosamide. The tablets are for prescription only and should only be dispensed by a pharmacist with a medication guide. The recommended usual dosage can be found in the enclosed information packet. The medication should be stored at room temperature and is packaged and distributed by MR Pharmaceuticals.*
Description: Lacosamide Tablets, USP is a prescription medicine that comes in unit dose with 60 tablets. It contains 100 ml of Lacosamide in each tablet. It should be stored at 20°C to 26°C and dispensed by a pharmacist with the medication guide. The usual dosage information is provided in the insert. The manufacturer and distributor of the medicine is Major.*
This is a product description for Major's Lacosamide Tablets, USP. The tablets are available in a unit dose of 60 tablets, each containing 50 mg of Lacosamide. The usual dosage instructions are provided in the product insert. The medication guide must be given to the pharmacist before dispensing. The tablets must be stored at a temperature between 15°C and 25°C (59°F and 77°F) and must be kept out of reach. There is also a lot number and expiry date provided.*
The text is showing a graph which demonstrates median percent reduction in seizure frequency per 28 days from baseline to the maintenance phase by dose for various drugs. The drugs featured are Paceto and Lacosamide. The graph shows statistically significant differences compared to placebo.*
This is a figure showing the proportion of patients by responder rate for Lacosamide and Placebo Groups in studies 2, 3, and 4. There are different groups with different dosages of Lacosamide (200 mg/day, 400 mg/day, and 600 mg/day) and a placebo group (Ne359). The responder rate is not specified.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.